Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Mohamed Elagawanya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Damanhour University, Damanhour, EgyptCorrespondence[email protected]

https://orcid.org/0000-0002-1597-5324 View further author information

Ayman Abo Elmaatyb Department of Medicinal Chemistry, Faculty of Pharmacy, Port Said University, Port Said, EgyptView further author information

Ahmed Mostafac Center of Scientific Excellence for Influenza Viruses, National Research Centre, Cairo, Egypt;d Institute of Medical Microbiology, German Center for Infection Research (DZIF), Justus-Liebig University Giessen, Giessen, GermanyView further author information

Noura M. Abo Shamac Center of Scientific Excellence for Influenza Viruses, National Research Centre, Cairo, EgyptView further author information

Eman Y. Santalie Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif, Saudi ArabiaView further author information

Bahaa Elgendyf Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences, St. Louis, MO, USA;g Chemistry Department, Faculty of Science, Benha University, Benha, EgyptView further author information

Ahmed A. Al-Karmalawyh Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, EgyptCorrespondence[email protected]

https://orcid.org/0000-0002-8173-6073 View further author information

show all

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date